Literature DB >> 33322542

Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.

Soha Mcheik1, Leticia Aptecar1, Peter Coopman1,2, Véronique D'Hondt1, Gilles Freiss1.   

Abstract

In this review article, we present the current knowledge on PTPN13, a class I non-receptor protein tyrosine phosphatase identified in 1994. We focus particularly on its role in cancer, where PTPN13 acts as an oncogenic protein and also a tumor suppressor. To try to understand these apparent contradictory functions, we discuss PTPN13 implication in the FAS and oncogenic tyrosine kinase signaling pathways and in the associated biological activities, as well as its post-transcriptional and epigenetic regulation. Then, we describe PTPN13 clinical significance as a prognostic marker in different cancer types and its impact on anti-cancer treatment sensitivity. Finally, we present future research axes following recent findings on its role in cell junction regulation that implicate PTPN13 in cell death and cell migration, two major hallmarks of tumor formation and progression.

Entities:  

Keywords:  PTPN13; cancer; cell signaling; oncogene; tumor suppressor

Year:  2020        PMID: 33322542      PMCID: PMC7763032          DOI: 10.3390/biom10121659

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  146 in total

1.  Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.

Authors:  Satoshi Kawano; Wataru Ikeda; Megumi Kishimoto; Hisakazu Ogita; Yoshimi Takai
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

2.  Molecular cloning of a mouse epithelial protein-tyrosine phosphatase with similarities to submembranous proteins.

Authors:  W Hendriks; J Schepens; D Bächner; J Rijss; P Zeeuwen; U Zechner; H Hameister; B Wieringa
Journal:  J Cell Biochem       Date:  1995-12       Impact factor: 4.429

3.  Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter.

Authors:  J Ying; H Li; Y Cui; A H Y Wong; C Langford; Q Tao
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

4.  Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene.

Authors:  Weiqi Huang; Ling Bei; Elizabeth A Eklund
Journal:  Leuk Lymphoma       Date:  2012-09-05

5.  Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.

Authors:  D Gardiol; C Kühne; B Glaunsinger; S S Lee; R Javier; L Banks
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

6.  Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.

Authors:  J-H Zhu; R Chen; W Yi; G T Cantin; C Fearns; Y Yang; J R Yates; J-D Lee
Journal:  Oncogene       Date:  2007-11-05       Impact factor: 9.867

7.  Interaction of Necl-4/CADM4 with ErbB3 and integrin α6 β4 and inhibition of ErbB2/ErbB3 signaling and hemidesmosome disassembly.

Authors:  Hirokazu Sugiyama; Kiyohito Mizutani; Souichi Kurita; Naomasa Okimoto; Yohei Shimono; Yoshimi Takai
Journal:  Genes Cells       Date:  2013-04-24       Impact factor: 1.891

8.  Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.

Authors:  Paola D Vermeer; Paul L Colbert; Bryant G Wieking; Daniel W Vermeer; John H Lee
Journal:  Cancer Res       Date:  2013-06-28       Impact factor: 12.701

9.  Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.

Authors:  Naiara C Cinegaglia; Sonia Cristina S Andrade; Tomas Tokar; Maísa Pinheiro; Fábio E Severino; Rogério A Oliveira; Erica N Hasimoto; Daniele C Cataneo; Antônio J M Cataneo; Júlio Defaveri; Cristiano P Souza; Márcia M C Marques; Robson F Carvalho; Luiz L Coutinho; Jefferson L Gross; Silvia R Rogatto; Wan L Lam; Igor Jurisica; Patricia P Reis
Journal:  Oncotarget       Date:  2016-05-17

10.  miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13.

Authors:  Shudi Xu; Tao Wang; Zhiwei Yang; Ying Li; Weijie Li; Ting Wang; Shan Wang; Lintao Jia; Shengli Zhang; Shengqing Li
Journal:  Oncotarget       Date:  2016-07-19
View more
  5 in total

Review 1.  Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome.

Authors:  Cristina Cristofoletti; Antonella Bresin; Martina Fioretti; Giandomenico Russo; Maria Grazia Narducci
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

2.  Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains.

Authors:  Hirofumi Nagao; Weikang Cai; Nicolai J Wewer Albrechtsen; Martin Steger; Thiago M Batista; Hui Pan; Jonathan M Dreyfuss; Matthias Mann; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

3.  PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis.

Authors:  Wenbin Kuang; Xiao Wang; Jiayu Ding; Jiaxing Li; Minghui Ji; Weijiao Chen; Liping Wang; Peng Yang
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

4.  Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration.

Authors:  Xiaoman Zhu; Zhiyang Chen; Li Wang; Qingjian Ou; Zhong Feng; Honglei Xiao; Qi Shen; Yingao Li; Caixia Jin; Jing-Ying Xu; Furong Gao; Juan Wang; Jingfa Zhang; Jieping Zhang; Zhiguo Xu; Guo-Tong Xu; Lixia Lu; Haibin Tian
Journal:  Cell Death Dis       Date:  2022-09-12       Impact factor: 9.685

5.  Protein Phosphorylation in Cancer: Unraveling the Signaling Pathways.

Authors:  Peter Coopman
Journal:  Biomolecules       Date:  2022-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.